Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.44 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.40 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8211430 | 0.98 | CA1 (0.45) | CA1CA2SLC15A1FDPSCYP3A4 | |
| SCHEMBL27934015 | 0.92 | CA1 (0.53) | CA1FDPSACE2ZDHHC7 | |
| SCHEMBL27705258 | 0.92 | CA1 (0.53) | CA1FDPSACE2ZDHHC7 | |
| SCHEMBL3683616 | 0.92 | CA1 (0.53) | CA1FDPSACE2ZDHHC7 | |
| SCHEMBL27941132 | 0.92 | CA1 (0.53) | CA1FDPSACE2ZDHHC7 | |
| SCHEMBL29030101 | 0.92 | CA1 (0.53) | CA1FDPSACE2ZDHHC7 | |
| SCHEMBL4437589 | 0.92 | CA1 (0.53) | CA1FDPSACE2ZDHHC7 | |
| Hydrochloric Acid SCHEMBL28874235 | 0.90 | CA1 (0.52) | CA1FDPSACE2ZDHHC7 | |
| Hydrochloric Acid SCHEMBL28791309 | 0.90 | CA1 (0.52) | CA1FDPSACE2ZDHHC7 | |
| Hydrochloric Acid SCHEMBL28252093 | 0.90 | CA1 (0.52) | CA1FDPSACE2ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108948141-B | 3R-indolylmethyl-6S-Pro modified piperazine-2, 5-dione, synthesis, activity and application thereof | 首都医科大学 | 2021-08-24 | — | — | CN | claimed |
| CN-108929369-B | 3R-indolylmethyl-6R-acidic amino acid modified piperazine-2, 5-dione, and synthesis, activity and application thereof | 首都医科大学 | 2021-08-24 | — | — | CN | claimed |
| CN-108976277-B | 3R-indolylmethyl-6S-polar amino acid modified piperazine-2, 5-dione, and synthesis, activity and application thereof | 首都医科大学 | 2021-07-02 | — | — | CN | claimed |
| CN-108929313-B | 3R-indolylmethyl-6R-aliphatic amino acid modified piperazine-2, 5-dione, and synthesis, activity and application thereof | 首都医科大学 | 2021-06-08 | — | — | CN | claimed |
| CN-108976147-B | Amino n-hexanoyl amido methyl-n-hexanoyl basic amino acid, synthesis, activity and application thereof | 首都医科大学 | 2021-02-12 | — | — | CN | claimed |
| CN-108929315-B | 3R-indolylmethyl-6S-methionine modified piperazine-2, 5-dione, and synthesis, activity and application thereof | 首都医科大学 | 2021-02-12 | — | — | CN | claimed |
| CN-109456311-B | 3R-indolylmethyl-6R-aromatic amino acid modified piperazine-2, 5-diketone and synthesis, activity and application thereof | 首都医科大学 | 2021-02-12 | — | — | CN | claimed |
| CN-108947977-B | Piperazine-2, 5-diketone modified by 3R-indolylmethyl-6R-amide side chain amino acid, and synthesis, activity and application thereof | 首都医科大学 | 2021-02-12 | — | — | CN | claimed |
| CN-108976201-B | 3R-indolylmethyl-6S-aromatic amino acid modified piperazine-2, 5-dione, and synthesis, activity and application thereof | 首都医科大学 | 2021-02-12 | — | — | CN | claimed |
| CN-109081790-B | Amino n-hexanoyl amido methyl-n-hexanoyl basic amino acid, synthesis, activity and application thereof | 首都医科大学 | 2021-02-12 | — | — | CN | claimed |
| CN-109081789-B | Amino n-hexanoyl amido methyl-acylamino n-hexanoyl fatty amino acid, synthesis, activity and application thereof | 首都医科大学 | 2021-01-01 | — | — | CN | claimed |
| CN-108976145-B | Amino n-hexanoyl amido methyl-acylamino n-hexanoyl polar amino acid, synthesis, activity and application thereof | 首都医科大学 | 2020-12-01 | — | — | CN | claimed |
| CN-108976146-B | Amino n-hexanoyl methyl cyclamido n-hexanoyl aromatic amino acid, synthesis, activity and application thereof | 首都医科大学 | 2020-11-27 | — | — | CN | claimed |
| CN-108929320-B | 3R-indolylmethyl-6R-oxazolidinone modified piperazine-2, 5-dione, synthesis, activity and application thereof | 首都医科大学 | 2020-10-16 | — | — | CN | claimed |
| CN-108947979-B | 3R-indolylmethyl-6R-polar amino acid modified piperazine-2, 5-dione, and synthesis, activity and application thereof | 首都医科大学 | 2020-10-16 | — | — | CN | claimed |
| CN-109134328-B | Amino n-caproyl methyl cyclo amido n-caproyl Met, its synthesis, activity and application | 首都医科大学 | 2020-06-19 | — | — | CN | claimed |
| CN-108947981-B | 3R-indolylmethyl-6S-aliphatic amino acid modified piperazine-2, 5-dione, and synthesis, activity and application thereof | 首都医科大学 | 2020-06-19 | — | — | CN | claimed |
| CN-112739683-B | Preparation method of brivaracetam and intermediate thereof | 上海宣泰医药科技股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-1642906-A | Novel arylamidine derivative or salt thereof | TOYAMA CHEMICAL CO LTD (JP) | 2005-07-20 | — | — | CN | disclosed |
| WO-1997046098-A9 | CLUSTER CLEARING AGENTS | — | 1998-08-06 | — | — | WO | disclosed |